Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review

被引：3
|
作者：
Xu, Jiamin [1 ]
Mu, Shukun [2 ]
Wang, Yun [2 ]
Yu, Suchun [3 ]
Wang, Zhongming [2 ]
机构：
[1] Univ Shanghai Sci & Technol, Sch Hlth Sci & Engn, Shanghai, Peoples R China
[2] Univ Shanghai Sci & Technol, Shidong Hosp Affiliated, Dept Radiat Oncol, Yangpu Dist, Shanghai, Peoples R China
[3] Univ Shanghai Sci & Technol, Shidong Hosp Affiliated, Dept Pharm, Yangpu Dist, Shanghai, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
melanoma; immune checkpoint inhibitors; radiotherapy; combination therapy; oncolytic virus; PLUS IPILIMUMAB; UVEAL MELANOMA; NIVOLUMAB; PEMBROLIZUMAB; RELATLIMAB; CANCER; RESPONSES; OUTCOMES; DISEASE; TRIAL;
D O I：
10.3389/fonc.2024.1400193
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The incidence of melanoma is increasing year by year and is highly malignant, with a poor prognosis. Its treatment has always attracted much attention. Among the more clinically applied immunotherapies are immune checkpoint inhibitors, bispecific antibodies, cancer vaccines, adoptive cell transfer therapy, and oncolytic virotherapy. With the continuous development of technology and trials, in addition to immune monotherapy, combinations of immunotherapy and radiotherapy have shown surprising efficacy. In this article, we review the research progress of immune monotherapy and combination therapy for advanced melanoma, with the aim of providing new ideas for the treatment strategy for advanced melanoma.
引用
收藏
页数：11
相关论文
共 50 条
  • [21] Combination or single-agent ipilimumab as immunotherapy of advanced melanoma: a critical review
    Abdel-Rahman, Omar
    MELANOMA MANAGEMENT, 2016, 3 (03) : 231 - 243
  • [22] Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma
    Laface, Carmelo
    Ranieri, Girolamo
    Maselli, Felicia Maria
    Ambrogio, Francesca
    Foti, Caterina
    Ammendola, Michele
    Laterza, Marigia
    Cazzato, Gerardo
    Memeo, Riccardo
    Mastrandrea, Giovanni
    Lioce, Marco
    Fedele, Palma
    CANCERS, 2023, 15 (03)
  • [23] Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
    Guo, Yuanyuan
    Gao, Fengyuan
    Ahmed, Adeel
    Rafiq, Muhammad
    Yu, Bing
    Cong, Hailin
    Shen, Youqing
    JOURNAL OF MATERIALS CHEMISTRY B, 2023, 11 (36) : 8586 - 8604
  • [24] Advances in targeted therapy and immunotherapy for melanoma (Review)
    Qin, Ziyao
    Zheng, Mei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (03)
  • [25] Recent advances in immunotherapy, immunoadjuvant, and nanomaterial-based combination immunotherapy
    Zhou, Benqing
    Liu, Jinxing
    Lin, Meiai
    Zhu, Jingyi
    Chen, Wei R.
    COORDINATION CHEMISTRY REVIEWS, 2021, 442
  • [26] Combination Immunotherapy for Advanced Melanoma-How to Choose?
    Kreft, Sophia
    Lorigan, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (04)
  • [27] From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review
    Kuryk, Lukasz
    Bertinato, Laura
    Staniszewska, Monika
    Pancer, Katarzyna
    Wieczorek, Magdalena
    Salmaso, Stefano
    Caliceti, Paolo
    Garofalo, Mariangela
    CANCERS, 2020, 12 (10) : 1 - 20
  • [28] Recent Advances in Targeted Therapies for Advanced Gastrointestinal Malignancies
    Huynh, Jasmine C.
    Schwab, Erin
    Ji, Jingran
    Kim, Edward
    Joseph, Anjali
    Hendifar, Andrew
    Cho, May
    Gong, Jun
    CANCERS, 2020, 12 (05)
  • [29] Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma
    Aitcheson G.
    Pillai A.
    Dahman B.
    John B.V.
    Current Hepatology Reports, 2021, 20 (1) : 23 - 33
  • [30] Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer
    Yue, Shiwei
    Zhang, Yunpu
    Zhang, Wei
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (08) : 1089 - 1111
12345